
The Burden of Psoriasis: A Silent Epidemic
Psoriasis, a chronic autoimmune disease, affects millions worldwide. While treatments have advanced, effectively managing the condition remains a challenge. PASI (Psoriasis Area and Severity Index) is a crucial tool for assessing disease severity, but traditional methods of calculating PASI are time-consuming and prone to errors.

The Impact of Uncontrolled Psoriasis
Psoriasis is more than skin deep.
It can significantly impact patients’ quality of life, leading to physical discomfort, emotional distress, and social isolation. Moreover, uncontrolled psoriasis increases the risk of comorbidities such as cardiovascular disease, metabolic syndrome, and depression.

The Need for Efficient Disease Management
Healthcare providers face the challenge of accurately assessing psoriasis severity and tailoring treatment plans accordingly.
Manual PASI calculations are time-consuming, leading to delays in treatment initiation and suboptimal patient outcomes.

Kribado: Your Partner in Psoriasis Care
Kribado offers a revolutionary solution. By integrating the PASI score into a user-friendly platform, we empower healthcare providers to:
- Quickly assess psoriasis severity: Obtain accurate PASI scores in seconds for efficient patient triage.
- Improve treatment adherence: Monitor disease progression and adjust treatment plans accordingly.
- Enhance patient experience: Provide personalized care and support to improve patient outcomes.
- Generate valuable insights: Collect and analyze patient data to inform clinical research and development.

A Proven Track Record
With a strong foundation in the pharmaceutical industry,
we understand the challenges you face. Our partnership with healthcare providers and pharmaceutical companies has enabled us to develop innovative solutions that drive real-world impact.